Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

Cited by (999)

Items 901–999 of 999

1. The prognostic role of late gadolinium enhancement on cardiac magnetic resonance in patients with nonischemic cardiomyopathy and reduced ejection fraction, implanted with cardioverter defibrillators for primary prevention. A systematic review and meta-analysis
   Ioannis Anagnostopoulos, Maria S. Kousta, Charalampos Kossyvakis, Eleni Lakka, Nikolaos Taxiarchis Paraskevaidis, Nikolaos C. Schizas, Nikolaos A. Alexopoulos, Spyridon G. Deftereos, Γεώργιος Γιαννόπουλος · 2021 · Journal of Interventional Cardiac Electrophysiology
2. Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era
   Gherardo Finocchiaro, Emma Forton Magavern, Georgios Georgioupoulos, Niccolò Maurizi, Gianfranco Sinagra, Gerald Carr‐White, Antonis A. Pantazis, Iacopo Olivotto · 2022 · Heart Failure Reviews
3. Combination of High-Density and Coherent Mapping for Ablation of Ventricular Arrhythmia in Patients with Structural Heart Disease
   Vanessa Sciacca, Thomas Fink, Leonard Bergau, Guram Imnadze, Mustapha El Hamriti, Denise Guckel, MARTIN U. BRAUN, Moneeb Khalaph, Philipp Sommer, Christian Sohns · 2022 · Journal of Clinical Medicine
4. Primary prevention implantable cardioverter-defibrillator use in non-ischemic dilated cardiomyopathy based on arrhythmic risk stratification and left ventricular reverse remodeling prediction
   Ahmed M Muhammed, Mohamed Abdelazeem, Mohammad Gamal Elewa, Mohamed Sharief, Ahmed Shafie Ammar · 2022 · Heart Failure Reviews
5. Imaging for risk stratification of sudden cardiac death
   Pieter van der Bijl, Jeroen Joost Bax · 2022 · Herzschrittmachertherapie + Elektrophysiologie
6. Heart Failure Burden by Autopsy, Guideline-Directed Medical Therapy, and ICD Utilization Among Sudden Deaths
   Satvik Ramakrishna, James W. Salazar, Jeffrey E. Olgin, Ellen Moffatt, Zian H. Tseng · 2022 · JACC. Clinical electrophysiology
7. Sudden Cardiac Death
   Pasquale Santangeli, Andrew E. Epstein · 2017 · Cardiac Electrophysiology Clinics
8. A risk score to predict the absence of left ventricular reverse remodeling: Implications for the timing of ICD implantation in primary prevention
   Jordi Pérez‐Rodon, Enrique Galve, Carmen Pérez‐Bocanegra, Teresa Soriano Sánchez, Jesús Recio Iglesias, Eva Domingo Baldrich, Mila Alzola-Guevara, Ignacio Ferreira González, Josep Ramón Marsal, Aída Ribera et al. · 2017 · Journal of Cardiology
9. Long‐term outcomes after prophylactic ICD and CRT‐D implantation in nonischemic patients: Analysis from a nationwide database of daily remote‐monitoring transmissions
   Giovanni B. Forleo, Francesco Solimene, Ennio Pisanò, Gabriele Zanotto, Valeria Ilia Calvi, Carlo Pignalberi, Giampiero Maglia, Saverio Iacopino, Fabio Quartieri, Mauro Biffi et al. · 2019 · Journal of Cardiovascular Electrophysiology
10. Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project
    Markus Zabel, Simon Schlögl, Andrzej Lubiński, Jesper Hastrup Svendsen, Axel Bauer, Elena Arbelo, Sandro Brusich, David Conen, Iwona Cygankiewicz, Michael Dommasch et al. · 2019 · Journal of Electrocardiology
11. Relation between resting heart rate and the risk of ventricular tachyarrhythmias in MADIT-RIT
    Roy Beinart, Valentina Kutyifa, Scott A McNitt, David Tsu-Chau Huang, Mehmet K. Aktaş, Spencer Z. Rosero, Ilan Goldenberg, Eyal Nof · 2019 · EP Europace
12. Electrocardiogram as a predictor of survival without appropriate shocks in primary prophylactic ICD patients: A retrospective multi-center study
    Ari Pelli, Tuomas V Kenttä, Juhani M. Junttila, Leonard Bergau, Markus Zabel, Marek Malík, Tobias Reichlin, Rik Willems, Marc A. Vos, Markus Harden et al. · 2020 · International Journal of Cardiology
13. Incremental value of Late Gadolinium Enhancement by Cardiac MRI in risk stratification of heart failure patients with moderate and severe LV dysfunction
    Laxman Kolluru, Jwala Srikala M, H. Nagaraj Rao, Sania Maheen, B. Hygriv Rao · 2020 · Indian Heart Journal
14. Withdrawn as duplicate: Optimized Implementation of cardiac resynchronization therapy – a call for action for referral and optimization of care
    Wilfried Müllens, Angelo Auricchio, Pieter Martens, Klaus Karl Witte, Martín Cowie, Victoria Delgado, Kenneth Dickstein, Cecilia Marianne Linde, Kevin Vernooy, Francisco Leyva et al. · 2021 · EP Europace
15. The role of multimodality imaging in the selection for implantable cardioverter‐defibrillators in heart failure: A narrative review
    Andreea Elena Velcea, Sorina Baldea Mihaila, Alina Ioana Nicula, Dragoş Vinereanu · 2022 · Journal of Clinical Ultrasound
16. Frequent Premature Ventricular Contractions and Cardiomyopathy, Chicken and Egg situation
    Kıvanç Yalın, Ebru Gölcük · 2017 · Journal of Atrial Fibrillation
17. Use of Contemporary Imaging Techniques for Electrophysiological and Device Implantation Procedures
    Angelo Auricchio, Francesco Fulvio Faletra · 2019 · JACC. Cardiovascular imaging
18. Cardiovascular Outcomes in Anthracycline-Related Cardiomyopathy
    Michael G. Fradley, Tomas G. Neilan · 2016 · JACC. Clinical electrophysiology
19. Implantable Cardioverter-Defibrillators Have Stood the Test of Time!
    Sana M. Al‐Khatib, Fred M Kusumoto · 2019 · Circulation
20. Identifying nonischemic cardiomyopathy patients who would benefit from an implantable cardioverter-defibrillator: Can late gadolinium enhancement on cardiovascular magnetic resonance imaging help?
    Rajat Kalra, Chetan Shenoy · 2019 · American Heart Journal
21. Primary prevention of sudden death with the implantable cardioverter defibrillator: bridging the evidence gap
    N.A. Mark Estes, Samir Saba · 2020 · European Heart Journal
22. Jahresbericht 2019 des Deutschen Herzschrittmacher- und Defibrillator-Registers – Teil 2: Implantierbare Kardioverter-Defibrillatoren (ICD)
    Andreas Markewitz, Bundesfachgruppe Herzschrittmacher und Defibrillatoren, S. Behrens, Christof Kolb, Bernd Lemke, G. Fröhlig, FRANK NOACK, Julius van Essen, Christoph Stellbrink, Heiko Bürger et al. · 2021 · Herzschrittmachertherapie + Elektrophysiologie
23. CRT-D or CRT-P?: the endless debate!
    Claude Daubert · 2023 · EP Europace
24. Strategies for Optimizing Heart Failure Care in the Older Adult: A Scientific Statement From the American Heart Association
    Sabra C. Lewsey, Trejeeve Martyn, Vanessa L. Blumer, Nicholas Keisuke Brownell, Quin E. Denfeld, Shannon M. Dunlay, Parag Goyal, Shannon Halloway, Daniel Matlock, Orly Vardeny et al. · 2026 · Circulation
25. Survival, ventricular arrhythmia, and implantable cardioverter‐defibrillator usefulness in toxic cardiomyopathy due to substance abuse
    Nicolas Dognin, Goran Rimac, Guillaume Domain, Alexandre Cinq‐Mars, Montse Massot, Pierre Yves Turgeon, Sacha‐Michelle Dubois‐Sénéchal, Christine Bourgault, Joëlle Morin, Mathieu Bernier et al. · 2023 · Pacing and Clinical Electrophysiology
26. Late-gadolinium enhancement predicts appropriate device therapies in nonischemic recipients of primary prevention implantable cardioverter-defibrillators
    Alan Kiang, Danah Al-Deiri, Tom Kai Ming Wang, Reza Nezafat, Diane Rizkallah, Thomas D. Callahan, Justin Z. Lee, Pasquale Santangeli, Oussama M. Wazni, Niraj Varma et al. · 2025 · Heart Rhythm
27. Nexilin mutations, a cause of chronic heart failure: A state-of-the-art review starting from a clinical case
    Oana-Cornelia Năstasie, Dan-Andrei Radu, Sebastian Onciul, Marian-Bogdan Drăgoescu, Nicoleta‐Monica Popa‐Fotea · 2025 · World Journal of Cardiology
28. Cardiac resynchronization therapy risk stratified by magnetic resonance imaging and optimized by left bundle branch pacing: Results from long-term follow-up of MADURAI LBBP study
    Shunmuga Sundaram Ponnusamy, Vidhya Ganesan, Vadivelu Ramalingam, Habibullah Moghal, Saravana Kumar, Ramvivek Ramamoorthy, Thabish Syed, Mariappan Murugan, Pugazhendhi Vijayaraman · 2025 · Heart Rhythm
29. CRO-INSIGHT: Utilization of Implantable Cardioverter Defibrillators in Non-ischemic and Ischemic Cardiomyopathy in a Single Croatian Tertiary Hospital Centre
    Mislav Puljević, E Ciglenecki, Vedran Pašara, Ivan Prepolec, Mia Dubravčić, Pero Hrabač, Ana-Marija Brekalo, Martina Lovrić Benčić, Miroslav Krpan, Richard Matasić et al. · 2025 · Reviews in Cardiovascular Medicine
30. Implantable Cardioverter–Defibrillators in Nonischemic Cardiomyopathy
    Rebecca E. Berger, Kenneth A. Ellenbogen, William G. Stevenson · 2016 · New England Journal of Medicine
31. Sex-Specific Outcomes in Cardiovascular Device Evaluations
    Mohammed Imran Ghare, Daniela Tı̂rziu, Jinnette Dawn Abbott, Elissa S. Altin, Yiping Yang, Vivian G. Ng, Cindy Lee Grines, Alexandra J. Lansky · 2020 · Journal of Women s Health
32. Indications for Implantable Cardioverter Defibrillators
    Panagiotis G. Korantzopoulos, Tong Liu · 2020 · Contemporary cardiology
33. Explaining Sex Differences in Cardiac Resynchronisation Therapy Outcome
    Alwin Zweerink, Elise Bakelants, Cornelis P. Allaart, Haran Burri · 2020 · European Journal of Arrhythmia & Electrophysiology
34. State-of-the-art narrative review: multimodality imaging in electrophysiology and cardiac device therapies
    Balint Laczay, Divyang Rajesh Patel, Richard A. Grimm, Bo Xu · 2021 · Cardiovascular Diagnosis and Therapy
35. Epicardial Adipose Tissue Measured From Computed Tomography Predicts Cardiac Resynchronization Therapy Response in Patients With Non-ischemic Systolic Heart Failure
    Huiyuan Qin, Cheng Wang, Duoduo Qian, Chang Cui, Minglong Chen · 2021 · Frontiers in Cardiovascular Medicine
36. Implantable cardioverter-defibrillators and the older patient: the Dutch clinical practice
    Dilek Yilmaz, Anastasia D. Egorova, Martin Jan Schalij, Lieselot van Erven · 2021 · European Journal of Cardiovascular Nursing
37. Prediction of prognosis in patients with left ventricular dysfunction using three-dimensional strain echocardiography and cardiac magnetic resonance imaging
    M. F. A. Aly, Sebastiaan A. Kleijn, J. H. van Lenthe, R. F. Menken-Negroiu, Lourens F. H. J. Robbers, A. M. Beek, Otto Kamp B · 2022 · Netherlands Heart Journal
38. Usefulness of the MADIT-ICD Benefit Score in a Large Mixed Patient Cohort of Primary Prevention of Sudden Cardiac Death
    Kevin Willy, Julia Köbe, Florian Reinke, Benjamin Rath, Christian Ellermann, Julian Wolfes, Felix Konrad Wegner, Patrick R. Leitz, Philipp Sebastian Lange, Lars Eckardt et al. · 2022 · Journal of Personalized Medicine
39. Temporal association between drops in thoracic impedance and malignant ventricular arrhythmia: A longitudinal analysis of remote monitoring trends
    Giovanna Rodio, Saverio Iacopino, Ennio Pisanò, Valeria Ilia Calvi, Giovanni Rovaris, Massimiliano Marini, Massimo Giammaria, Fabrizio Caravati, Giampiero Maglia, Gabriele Zanotto et al. · 2023 · Journal of Cardiovascular Electrophysiology
40. The impact of implantable cardioverter defibrillator on the prognosis of nonischemic dilated cardiomyopathy patients compared with standard medical treatments
    Hossein Salehi Omran, Farah Naghashzadeh, Rana Irilouzadian, Sina Dolatshahi, Mohammad Taghi Hedayati Goudarzi, Mohammad Taghi Salehi Omran · 2023 · Clinical Cardiology
41. Utilization of Regional Anesthesia in the Electrophysiology Lab: A Narrative Review
    David Oh, Gabriel Stapleton, Ethan Y. Brovman · 2023 · Current Pain and Headache Reports
42. Implantable Cardioverter Defibrillator in Patients With Nonischemic Systolic Heart Failure With and Without Cardiac Resynchronization Therapy: Extended Follow-Up Study of the DANISH Trial
    Jawad H. Butt, Adelina Yafasova, Seiko N. Doi, Jens Cosedis Nielsen, Jens Haarbo, Hans Eiskjær, Axel Brandes, Anna Margrethe Thøgersen, Finn Gustafsson, Christian Hassager et al. · 2023 · Circulation
43. Evaluation of MADIT-II Risk Stratification Score Among Nationwide Registry of Heart Failure Patients With Primary Prevention Implantable Cardiac Defibrillators or Resynchronization Therapy Devices
    Moshe Rav-Acha, Orli Wube, Oholi Tovia‐Brodie, Yoav Michowitz, Michael Ilan, Tal Ovdat, Robert Klempfner, Mahmud Suleiman, Ilan Goldenberg, Michael Glikson · 2023 · The American Journal of Cardiology
44. Long-term outcomes from upgrade to cardiac resynchronisation therapy in ischaemic versus non-ischaemic heart disease
    Goekhan Yuecel, Karolina Stoesslein, Leo Gaasch, Abbass Kodeih, Oezge Nur Oeztuerk, Svetlana Hetjens, Babak Yazdani, Stefan Pfleger, Volker Liebe, Boris Rudic et al. · 2023 · Acta cardiologica. Supplementum
45. Implantable Cardiac Devices in Patients with Brady- and Tachy-Arrhythmias: An Update of the Literature
    William Chick, Christopher A. Monkhouse, Amal G. Muthumala, Syed Ahsan, Νικόλαος Παπαγεωργίου · 2024 · Reviews in Cardiovascular Medicine
46. Sudden cardiac death risk stratification in heritable cardiomyopathies: phenotype-based to genotype-based risk scores
    Rafik Tadros · 2024 · European Heart Journal
47. Left Ventricular Ejection Fraction and Implantable Cardioverter Defibrillator in Nonischemic Heart Failure With Reduced Ejection Fraction: Insights From DANISH
    Seiko N. Doi, Jawad H. Butt, Jens Jakob Thune, Jens Cosedis Nielsen, Jens Haarbo, Niels Eske Bruun, Line Lisbeth Olesen, Lars Melgaard Videbæk, Finn Gustafsson, Hans Eiskjær et al. · 2024 · Circulation
48. How to Approach Left Ventricular Hypertrabeculation: A Practical Guide and Literature Review
    Michele Alfieri, Samuele Principi, Alessandro Barbarossa, Giulia Stronati, Roberto Antonicelli, Michela Casella, Antonio Dello Russo, Federico Guerra · 2025 · Journal of Clinical Medicine
49. Refining Patient Selection Criteria for LV-Only Fusion Pacing in Cardiac Resynchronization Therapy: A Systematic Review
    Adelina Andreea Faur-Grigori, Cristina Văcărescu, Samuel Nistor, Silvia Ana Luca, Liviu Cirin, Simina Crișan, Constantin Tudor Luca, Radu Gabriel Vatasescu, Dragoș Constantin Cozma · 2025 · Journal of Clinical Medicine
50. ESC-Leitlinie 2016 – Herzinsuffizienz
    Lucas Adrian, Christian D. Werner, Ulrich Laufs · 2017 · DMW - Deutsche Medizinische Wochenschrift
51. Devices in heart failure; diagnosis, detection and disease modification
    John Gierula, Mark T. Kearney, Klaus K. Witte · 2017 · British Medical Bulletin
52. Einsatz des tragbaren Kardioverter-Defibrillators nach kardiochirurgischen Eingriffen
    Heiko Bürger, J. Schmitt, Michael Knaut, Thomas Eitz, Christoph Thomas Starck, Samer Hakmi, Alexander Siebel, Andreas Böning · 2018 · Zeitschrift für Herz- Thorax- und Gefäßchirurgie
53. Current Management and Treatment
    Alessandro Altinier, Alessia Paldino, Marta Gigli, Aniello Pappalardo, Gianfranco Sinagra · 2019 · Springer eBooks
54. Personality traits, ventricular tachyarrhythmias, and mortality in patients with an implantable cardioverter defibrillator: 6 years follow-up of the WEBCARE cohort
    Eva Broers, Mirela Habibović, Johan Denollet, Jos W.M.G. Widdershoven, Marco Alings, Dominic A.M.J. Theuns, Pepijn van der Voort, Leon Bouwels, JEAN PAUL HERRMAN, Susanne S. Pedersen · 2019 · General Hospital Psychiatry
55. Deformación miocárdica en miocardiopatía dilatada no isquémica mediante feature tracking. Factibilidad e implicaciones pronósticas
    Javier Urmeneta Ulloa, Eduardo Pozo, Juan Lizandro Rodríguez Hernández, Hugo Martínez Fernández, Fabián Islas, Alberto de Agustín, Pedro Marcos‐Alberca, Patricia Mahía, Miguel Ángel Cobos, Paula Hernández Mateo et al. · 2020 · Revista Española de Cardiología
56. AnaLysIs of Both sex and device specific factoRs on outcomes in pAtients with non-ischemic cardiomyopathy (BIO-LIBRA): Design and clinical protocol
    Valentina Kutyifa, Mary W. Brown, Christopher A. Beck, Scott A McNitt, Crystal Miller, Karlene Cox, Wojciech Zaręba, Spencer Z. Rosero, Marye J. Gleva, Jeanne E. Poole · 2020 · Heart Rhythm O2
57. Trajectory of left ventricular ejection fraction among individuals eligible for implantable cardioverter‐defibrillator
    Selma Carlson, Amy A. Gravely, Selçuk Adabağ · 2021 · Pacing and Clinical Electrophysiology
58. Primary Prevention Implantable Cardioverter-Defibrillator Therapy in Heart Failure with Recovered Ejection Fraction
    Jayson R. Baman, Kaustubha D. Patil, Ankit N. Medhekar, Jane E. Wilcox · 2021 · Journal of Cardiac Failure
59. Peripoperative Mortalität nach ICD-Implantation
    Harilaos Bogossian, Dimitrios Panteloglou, Zana Karosiene, Susanne Macher-Heidrich, Heinz Jürgen Adomeit, Bernd Lemke, Carsten Walter Israel · 2021 · Herz
60. Association of Guideline-Based Medical Therapy with Malignant Arrhythmias and Mortality among Heart Failure Patients Implanted with Cardioverter Defibrillator (ICD) or Cardiac Resynchronization-Defibrillator Device (CRTD)
    Tal Hasin, Ilia Davarashvili, Yoav Michowitz, Rivka Farkash, Haya Presman, Michael Glikson, Moshe Rav-Acha · 2021 · Journal of Clinical Medicine
61. Risk stratification for sudden cardiac death in patients with heart failure
    Ikram Kammoun, Emna Bennour, Lobna Laroussi, Manel Miled, Ahmed Sghaier, R. Karmous, Amine Boussema, Sonia Marrakchi, Salem Kachboura · 2021 · Herz
62. Cost-effectiveness of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death
    Aída Ribera, Emmanuel Giménez, Gerard Oristrell, Dimelza Osorio, Josep Ramón Marsal, Lidia García‐Pérez, Mónica Ballesteros, Eduard Ródenas‐Alesina, Yassin Belahnech, Roxana Escalona et al. · 2021 · Revista Española de Cardiología (English Edition)
63. Testing for a Sweet Spot in Randomized Trials
    Donald A. Redelmeier, Deva Thiruchelvam, Robert John Tibshirani · 2021 · Medical Decision Making
64. Spanish Implantable Cardioverter-defibrillator Registry. 17th Official Report of the Heart Rhythm Association of the Spanish Society of Cardiology (2020)
    Ignacio Fernández Lozano, Joaquín Osca, Javier Alzueta Rodríguez · 2021 · Revista Española de Cardiología (English Edition)
65. Myocardial strain assessment using cardiovascular magnetic resonance imaging in recipients of implantable cardioverter defibrillators
    Nigel S. Tan, Djeven Parameshvara Deva, Kim Alexander Connelly, Paul Angaran, Iqwal Mangat, Laura Jiménez‐Juan, Ming‐Yen Ng, Kamran Ahmad, Vamshi Krishna Kotha, João A.C. Lima et al. · 2021 · Journal of Cardiovascular Magnetic Resonance
66. Performance of Coronary Angiography in the Detection of Coronary Artery Disease in Patients with Systolic Left Ventricular Dysfunction and No Prior Ischemic Heart Disease
    Óscar M. Peiró, Maria Ferrero, A Romeu, Anna Carrasquer, Gil Bonet, Mohsen Mohandes, Alberto Pernigotti, Alfredo Bardajı́ · 2022 · Journal of Clinical Medicine
67. Longitudinal Arrhythmic Risk Assessment Based on Ejection Fraction in Patients with Recent-Onset Nonischemic Dilated Cardiomyopathy
    Giulia De Angelis, Marco Merlo, Giulia Barbati, Silvia Bertolo, Antonio De Luca, Federica Ramani, Luigi Adamo, Gianfranco Sinagra · 2022 · Journal of the American Society of Echocardiography
68. Implantable cardiac defibrillators for patients with non-ischaemic cardiomyopathy
    Mohamad N. El Moheb, Johny Nicolas, Ghida Iskandarani, Elie A. Akl, Marwan M. Refaat · 2017 · Cochrane Database of Systematic Reviews
69. Myocardial fibrosis and ventricular ectopy in patients with non-ischemic systolic heart failure: results from the DANISH trial
    Marie Bayer Elming, Rune Boas, Sophia Hammer‐Hansen, Inga Voges, Eva G. Nyktari, Jesper Hastrup Svendsen, Steen Michael Pehrson, Ulrik Dixen, Berit T. Philbert, Sanjay Kumar Prasad et al. · 2022 · The International Journal of Cardiovascular Imaging
70. QRS fragmentation is associated with increased risk of ventricular arrhythmias in high‐risk patients; Data from the SMASH 1 Study
    Nur Sourour, Egil Riveland, Terje Rømo, Patrycja Anna Naesgaard, Harald Kjekshus, Alf Inge Larsen, Torbjørn Omland, Helge Rørvik Røsjø, Peder Langeland Myhre · 2022 · Annals of Noninvasive Electrocardiology
71. The Role of Genetics in Risk Stratification Strategy of Dilated Cardiomyopathy
    Anastasia Xintarakou, Ourania K. Kariki, Ioannis Doundoulakis, Πέτρος Αρσένος, Στέργιος Σουλαϊδόπουλος, Ageliki Laina, Panagiotis Xydis, Athanasios Kordalis, Nikolaos Nakas, Alexia Theofilou et al. · 2022 · Reviews in Cardiovascular Medicine
72. Meta-Analysis on Drug and Device Therapy of New York Heart Association Functional Class IV Heart Failure With Reduced Ejection Fraction
    R. Batchelor, Emilia Nan Tie, Lorena Romero, Ingrid Hopper, David M. Kaye · 2022 · The American Journal of Cardiology
73. Right Ventricular Free Wall Strain and Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure
    Marie Bayer Elming, DAVID HELLEMANN JENSEN, Ulrik Winsløw, Niels Risum, Jawad H. Butt, Adelina Yafasova, Jens Haarbo, Berit T. Philbert, Jesper Hastrup Svendsen, Steen Michael Pehrson et al. · 2023 · Journal of Cardiac Failure
74. Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study
    Balbir Bagicha Singh, Yu‐Cheng Hsieh, Yen‐Bin Liu, Kuo‐Hung Lin, Boyoung Joung, Diego Rodríguez, Alexandr Robertovich Chasnoits, Dejia Huang, Shu Zhang, Janet E. O'Brien et al. · 2023 · Indian Heart Journal
75. Follow-up of CRT-D patients downgraded to CRT-P at the time of generator exchange
    Simon Frey, Roman Brenner, Dominic A.M.J. Theuns, Naeem Alshoaibi, Richard Crawley, Peter Ammann, Christian Sticherling, Michael Kühne, Stefan Osswald, Beat Andreas Schaer · 2023 · Frontiers in Cardiovascular Medicine
76. An updated meta-analysis of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy
    Fuwei Liu, Xin Gao, Jun Luo · 2023 · Frontiers in Cardiovascular Medicine
77. Review of the National Institute for Health and Care Excellence guidelines on the management of atrial and ventricular arrhythmias
    Pier David Lambiase, Edd Maclean · 2023 · Heart
78. Topological data analysis to identify cardiac resynchronization therapy patients exhibiting benefit from an implantable cardioverter-defibrillator
    Boglárka Veres, Walter Richárd Schwertner, Márton Tokodi, Ádám Szijártó, Attila D Kovács, Eperke Dóra Merkel, A Behon, Luca Katalin Kuthi, Richard Masszi, László Gellér et al. · 2023 · Clinical Research in Cardiology
79. Review and critical appraisal of the indications for cardiac magnetic resonance imaging in the ESC guidelines
    Bernhard L. Gerber · 2023 · Acta cardiologica. Supplementum
80. Correlation of extent of left ventricular endocardial unipolar low-voltage zones with ventricular tachycardia in nonischemic cardiomyopathy
    Deep Chandh Raja, Jenish P. Shroff, Anugrah Nair, Sreevilasam Pushpangadhan Abhilash, Lukah Q. Tuan, Abhinav B. Mehta, Walter P. Abhayaratna, Prashanthan Sanders, David S. Frankel, Francis E. Marchlinski et al. · 2024 · Heart Rhythm
81. An unusual cause of inappropriate shocks delivered by an implantable cardioverter defibrillator
    Benito Jonas Baldauf, Ernest W. Lau, Marzia Giaccardi, Hendrik Bonnemeier · 2024 · BMC Cardiovascular Disorders
82. Heart failure disease management program, its contribution to established pharmacotherapy and long-term prognosis in real clinical practice - retrospective data analysis
    Marie Lazárová, Dušan Lazár, Filip Málek, Jan Václavík, Miloš Táborský, Andrew P. Ignaszewski · 2018 · Biomedical Papers
83. Primary prevention implantable cardioverter defibrillators in non‐ischaemic cardiomyopathy: challenging the Australian heart failure guidelines
    Dennis H. Lau, Jonathan M. Kalman, Prashanthan Sanders · 2019 · The Medical Journal of Australia
84. A Population-Based Study of Device Eligibility, Use, and Reasons for Nonimplantation in Patients at Heart Function Clinics
    Rochelle Bernier, Jessica Ng, Dat T. Tran, Evan E. Lockwood, Lucy Reyes, Karen F. Cowan, Nowell Mark Fine, Justin Adrian Ezekowitz, Derek V. Exner, Satish R. Raj et al. · 2019 · CJC Open
85. Heart Failure Patients Unresponsive to Implantable Cardioverter-Defibrillator Therapy: A Neglected Problem
    Marcello Disertori, Michela Masè, Marta Rigoni, Giandomenico Nollo, Flavia Ravelli · 2019 · European Journal of Heart Failure
86. Role of the proportion of sudden cardiac death to mortality for clinical effectiveness of primary prevention ICDs
    Markus Zabel, Tim Friede, Heikki V. Huikuri, Marek Malík, Rik Willems · 2020 · European Heart Journal
87. Contemporary management of heart failure patients with reduced ejection fraction: the role of implantable devices and catheter ablation
    Catrin Sohrabi, Syed Ahsan, Αlexandros Briasoulis, Emmanuel S. Androulakis, Gerasimos Siasos, Neil T. Srinivasan, Νικόλαος Παπαγεωργίου · 2021 · Reviews in Cardiovascular Medicine
88. An updated systematic review on heart failure treatments for patients with renal impairment: the tide is not turning
    Cong Ying Hey, Sérgio Barra, Rudolf Martin Duehmke, Stephen Pettit, Wayne C. Levy, José Silva‐Cardoso, Rui Andre Providencia · 2022 · Heart Failure Reviews
89. Spanish Implantable Cardioverter-defibrillator Registry. 14th Official Report of the Spanish Society of Cardiology Electrophysiology and Arrhythmias Section (2017)
    Ignacio Fernández Lozano, Joaquín Osca, Javier Alzueta Rodríguez · 2018 · Revista Española de Cardiología (English Edition)
90. Primary Prevention Implantable Cardioverter–Defibrillator Therapy: A Matter not Yet Adequately Explored Waiting for Guidelines Update
    Andrea Igoren Guaricci, Gianluca Pontone, Nicola Gaibazzi, Stefano Favale · 2017 · ESC Heart Failure
91. Insights from Second-Line Treatments for Idiopathic Dilated Cardiomyopathy
    Marco Luciani, Federica del Monte · 2017 · Journal of Cardiovascular Development and Disease
92. Management of Bradyarrhythmias in Heart Failure: A Tailored Approach
    Daniele Masarone, Ernesto Ammendola, Anna Rago, Rita Gravino, Gemma Salerno, Marta Rubino, Tommaso Marrazzo, Antonio Molino, Paolo Calabrò, Giuseppe Pacileo et al. · 2017 · Advances in experimental medicine and biology
93. Catheter Ablation for Ventricular Tachycardia in Patients with Structural Heart Disease
    Timothy M. Markman, Daniel A McBride, Jackson Jeikai Liang · 2018 · US Cardiology Review
94. Comparable survival in ischemic and nonischemic cardiomyopathy secondary to ventricular tachyarrhythmias and aborted cardiac arrest
    Jonas Rusnak, Michael Behnes, Tobias Schupp, Christel Weiß, Christoph Anton Nienaber, Siegfried Lang, Linda Reiser, Armin Bollow, Gabriel Taton, Thomas Reichelt et al. · 2019 · Coronary Artery Disease
95. Impaired myocardial perfusion is associated with increasing end-systolic- and end-diastolic volumes in patients with non-ischemic systolic heart failure: a cross-sectional study using Rubidium-82 PET/CT
    Christina Byrne, Philip Hasbak, Andreas Kjær, Jens Jakob Thune, Lars Køber · 2019 · BMC Cardiovascular Disorders
96. Cardioverter–defibrillator does not improve short-term survival among patients with non-ischemic cardiomyopathy and reduced left ventricular ejection fraction
    Clemens Jilek, Thorsten Lewalter, Matthias Pauschinger, Wolfgang von Scheidt, Lutz Frankenstein, Otmar Pfister, Rainer Hambrecht, Oliver Bruder, Johannes Brachmann, Andreas Hartmann et al. · 2019 · Clinical Research in Cardiology
97. Sudden cardiac arrest and ventricular arrhythmias following first type I myocardial infarction in the contemporary era
    Mustapha Amin, Danesh Kella, Ammar M. Killu, Deepak Padmanabhan, David O. Hodge, Michael A. Golafshar, Alanna M. Chamberlain, Justin Z. Lee, Win-Kuang Shen, Paul A. Friedman et al. · 2019 · Journal of Cardiovascular Electrophysiology
98. Electroanatomic Ratios and Mortality in Patients With Heart Failure: Insights from the ASIAN‐HF Registry
    Janice Y. Chyou, Wan Ting Tay, Inder S. Anand, Tiew‐Hwa Katherine Teng, Jonathan Jiunn Liang Yap, Michael Ross MacDonald, Vijay Chopra, Seet Yoong Loh, Wataru Shimizu, Imran Zainal Abidin et al. · 2021 · Journal of the American Heart Association
99. Plötzlicher Herztod
    Boris Rudic, Erol Tülümen, Volker Liebe, Jürgen Kuschyk, İbrahim Akın, Martin M. Borggrefe · 2017 · Herz